Buyer Database · Buyer / Distributor · Updated
Columbia Pictures
Columbia Pictures is mid-campaign on a planned horror trilogy, leveraging the commercial and critical success of 28 Years Later to build franchise infrastructure around cerebral, genre-elevated content.
Current mandate
Columbia Pictures is currently in active release mode for 28 Years Later: The Bone Temple, the middle chapter of a new trilogy rooted in the 28 Days Later franchise, with a theatrical date of January 16, 2026. The studio has opened press screenings in both the U.S. and U.K. and is deploying social media reaction campaigns ahead of release, a signal of confidence in the film's word-of-mouth potential. Nia DaCosta's direction has drawn early descriptions of the film as "weirder" and "more brutal," with thematic territory spanning faith, cultism, and trauma. That positions Bone Temple as a more cerebral entry than its predecessors, and Columbia appears to be leaning into that framing rather than softening it.
Over the past twelve months, Columbia's most visible pattern has been franchise consolidation around proven genre IP with elevated creative credentials. The first film in the new trilogy, 28 Years Later, was released in June, earned an 89 percent critics score on Rotten Tomatoes, and grossed over $150 million at the box office against a $60 million budget. That performance is the explicit commercial foundation for the continuation. Danny Boyle is attached to direct the third film, reinforcing the studio's appetite for auteur-adjacent talent within genre frameworks. The studio's internal language, per tracked executive quotes, centers on visual spectacle and marketability: content that can "hang a campaign on."
For writers and producers seeking access, the clearest pathway runs through genre projects with strong visual hooks and franchise or sequel potential. Columbia is not signaling interest in standalone, low-concept horror at this moment. Projects that combine cerebral thematic depth with a clear, campaign-ready visual identity align most directly with what the studio is actively building. Seventeen decision makers are currently tracked across Columbia's acquisitions and development infrastructure.
Signature peaks
- 89% Critics Score — 28 Years Later on Rotten Tomatoes
- $150M+ Box Office Gross — 28 Years Later theatrical run
- 17 Decision Makers Tracked — Active across Columbia acquisitions and development
Mandate dimensions
- Genre focus
- action, comedy, drama, horror, thriller
- Territory focus
- Not disclosed
- Budget tier (observed)
- Not disclosed
- Access pattern
- Representation-only. Literary agent, entertainment attorney, or established producer with a Sony or Columbia relationship required. No open submission window is currently active. Projects with franchise potential and a strong visual hook are best positioned.
- Deal structure
- Studio-level production and distribution deals. Recent franchise activity reflects mid-to-large budget commitments (the 28 Years Later entry carried a reported $60 million budget). Deal structures are negotiated through standard studio development and co-production agreements; no acquisition-only or spec-script purchase activity is confirmed in the current 90-day window.
Market context
"We'll give you the money… if you show the inside of the mothership. Give us something we can hang a campaign on."
Columbia Pictures is currently in active release mode for 28 Years Later: The Bone Temple, the middle chapter of a new trilogy rooted in the 28 Days Later franchise, with a theatrical date of January 16, 2026. The studio has opened press screenings in both the U.S. and U.K. and is deploying social media reaction campaigns ahead of release, a signal of confidence in the film's word-of-mouth potential. Nia DaCosta's direction has drawn early descriptions of the film as "weirder" and "more brutal," with thematic territory spanning faith, cultism, and trauma. That positions Bone Temple as a more cerebral entry than its predecessors, and Columbia appears to be leaning into that framing rather than softening it.
Common questions about Columbia Pictures
Does Columbia Pictures accept unsolicited scripts?
Columbia Pictures, as a major studio under Sony Pictures Entertainment, does not accept unsolicited scripts through open submission channels. All material must arrive via a licensed literary agent, entertainment attorney, or established producer with an existing studio relationship. Attempting to submit directly to tracked executives without representation is unlikely to result in a read and may create legal complications for the submitting party.
What budget range does Columbia Pictures work with for genre acquisitions?
Based on available data, Columbia's recent genre franchise activity operates at the studio level. The 28 Years Later entry carried a reported $60 million production budget. While Columbia has historically distributed films across a range of budgets, current signals suggest the studio is focused on mid-to-large-scale genre productions with franchise potential rather than micro-budget acquisitions. No specific lower-budget acquisition thresholds are confirmed in recent coverage.
Does Columbia Pictures scout at film festivals for acquisitions?
Columbia Pictures is a production and distribution entity rather than a traditional festival acquisitions buyer. Its current activity centers on internally developed or pre-packaged franchise projects. That said, festival breakouts with strong genre credentials and marketable hooks can attract attention from Sony-affiliated labels and producers with Columbia relationships. A festival premiere can serve as a proof-of-concept that opens doors to those intermediaries.
How do you get a script or project to Columbia Pictures decision makers?
The most direct pathway, based on current studio posture, is through representation or a producer already in business with Columbia or Sony Pictures. Seventeen decision makers are tracked across the studio's acquisitions and development infrastructure. The studio's own language emphasizes projects with a clear visual identity and campaign-ready hook, so packaging material with a director or notable talent before approaching increases the likelihood of engagement.
What genres is Columbia Pictures prioritizing right now?
Current signals point strongly toward elevated genre horror with franchise or trilogy potential. The studio is mid-execution on the 28 Days Later franchise continuation, with thematic territory described as covering faith, cultism, and trauma. Early reactions to Bone Temple emphasize a cerebral, brutal tone. Columbia's internal framing, per tracked executive quotes, favors projects with a strong visual spectacle component and a marketable, campaign-ready concept at their core.
Is Columbia Pictures actively acquiring new projects right now?
No new acquisitions appear in Columbia's tracked deal activity over the past 30 to 90 days, according to available records. The studio's current energy is concentrated on releasing and marketing 28 Years Later: The Bone Temple ahead of its January 16, 2026 theatrical date. With Danny Boyle attached to direct the third film in the trilogy, the franchise pipeline appears internally sourced for the near term. Broader acquisition activity may resume once the current release cycle concludes.
Adjacent buyers in this lane
- Signature Entertainment — Signature Entertainment is an active UK and Ireland distributor acquiring bold genre films, true-sto
- Nexstar — Nexstar is a dominant U.S. local broadcasting group operating across 160 markets, now leveraging its
- Highland Film Group — Highland Film Group is actively packaging and launching international sales on prestige-leaning genr
- ZDF Studios — ZDF Studios' fiction unit is actively marketing international scripted content and coproductions whi
Related reading
Match your script to Columbia Pictures
This is a public snapshot of Columbia Pictures, kept current from trade-press signals. Inside ScriptMatch, upload your script to see whether Columbia Pictures fits, why, and exactly how to reach them. Start a free 7-day trial or try the free buyer-match tool.